U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT06881160) titled 'Mi-RNA and COVID-19' on March 12, 2023.
Brief Summary: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), induces a spectrum of clinical conditions ranging from asymptomatic infection to life threatening severe disease, characterized by respiratory failure, shock and multi-organ dysfunction requiring admission in the intensive care unit (ICU).
The aim of the present study is to analyze miRNAs associated with SARS-CoV-2 infection, disease severity and mortality.
Study Start Date: March 01, 2020
Study Type: OBSERVATIONAL
Condition:
COVID-19
Intervention:
DIAGNOSTIC_T...